ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Innovative Cancer Therapies: Dr. Matthew Kurian's Insights on AI and Precision Oncology"
Episode Synopsis
Welcome to the Business Talk Podcast!
We are delighted to welcome the highly esteemed Dr. Matthew Kurian to join us today.
In this episode, Dr. Kurian will explore his expertise topic, "Transforming Cancer Care: How AI, Precision Medicine, and Innovative Therapies Are Shaping the Future of Oncology."
The landscape of cancer care is undergoing a revolutionary transformation, driven by advancements in artificial intelligence (AI), precision medicine, and innovative therapies. AI is enabling more accurate diagnosis, predictive analytics, and personalized treatment plans, allowing oncologists to detect cancer earlier and tailor interventions to individual patients. Precision medicine leverages genetic profiling to target therapies specific to a patient’s unique cancer mutations, increasing treatment efficacy and minimizing side effects. Breakthrough therapies, such as immunotherapy, radioligand treatments, and gene therapies, are providing new hope for patients with previously untreatable cancers.
Together, these innovations are reshaping oncology, offering more effective and personalized treatments, improving patient outcomes, and pushing cancer care into a new era of medical advancement. The future of oncology lies in integrating these technologies, making cancer treatment more adaptive, targeted, and accessible to all.
About the Guest:
Dr. Matthew Kurian is a dedicated hematology/oncology physician at St. Elizabeth Healthcare and an assistant professor of medicine at the University of Kentucky College of Medicine. Specializing in breast and genitourinary cancers, Dr. Kurian has a wealth of experience with radioligand therapies, particularly Lu-177. He completed his oncology fellowship at the NCI-designated University Hospitals/Case Comprehensive Cancer Center, where he served as the Chief Fellow of the Hematology/Oncology Fellowship Program for 2022-2023 and has numerous peer-reviewed publications to his name.
Beyond clinical practice, Dr. Kurian is passionate about narrative medicine, medical education, and improving clinical trial access in community settings. As the Cancer Center Physician Liaison at St. Elizabeth and a member of the Executive Committee of KYSCO (the state affiliate of ASCO), he aims to enhance the availability of GU and breast cancer trials in his region. He previously taught at Case Western Reserve University School of Medicine, earning the 2023 Fellow Teacher of the Year Award and being inducted into the Academy of Scholars.
This podcast is brought to you by Global Management Consultancy. For more information, please visit www.globalmanagementconsultancy.com.
Disclaimer:
A. The background music used in this video is the property of its respective developer and is protected by Copyright. Although it is a free version, Business Talk, Global Management Consultancy and Deepak Bhatt do not hold the rights to this music.
B. Dr. Matthew Kurian has granted permission to share insights from the topic, “Transforming Cancer Care: How AI, Precision Medicine, and Innovative Therapies Are Shaping the Future of Oncology” on Business Talk Podcast Channel. The uploaded video contains copyrighted material; therefore, any modifications to graphics, music, or the presence of the author or host are strictly prohibited.
We are delighted to welcome the highly esteemed Dr. Matthew Kurian to join us today.
In this episode, Dr. Kurian will explore his expertise topic, "Transforming Cancer Care: How AI, Precision Medicine, and Innovative Therapies Are Shaping the Future of Oncology."
The landscape of cancer care is undergoing a revolutionary transformation, driven by advancements in artificial intelligence (AI), precision medicine, and innovative therapies. AI is enabling more accurate diagnosis, predictive analytics, and personalized treatment plans, allowing oncologists to detect cancer earlier and tailor interventions to individual patients. Precision medicine leverages genetic profiling to target therapies specific to a patient’s unique cancer mutations, increasing treatment efficacy and minimizing side effects. Breakthrough therapies, such as immunotherapy, radioligand treatments, and gene therapies, are providing new hope for patients with previously untreatable cancers.
Together, these innovations are reshaping oncology, offering more effective and personalized treatments, improving patient outcomes, and pushing cancer care into a new era of medical advancement. The future of oncology lies in integrating these technologies, making cancer treatment more adaptive, targeted, and accessible to all.
About the Guest:
Dr. Matthew Kurian is a dedicated hematology/oncology physician at St. Elizabeth Healthcare and an assistant professor of medicine at the University of Kentucky College of Medicine. Specializing in breast and genitourinary cancers, Dr. Kurian has a wealth of experience with radioligand therapies, particularly Lu-177. He completed his oncology fellowship at the NCI-designated University Hospitals/Case Comprehensive Cancer Center, where he served as the Chief Fellow of the Hematology/Oncology Fellowship Program for 2022-2023 and has numerous peer-reviewed publications to his name.
Beyond clinical practice, Dr. Kurian is passionate about narrative medicine, medical education, and improving clinical trial access in community settings. As the Cancer Center Physician Liaison at St. Elizabeth and a member of the Executive Committee of KYSCO (the state affiliate of ASCO), he aims to enhance the availability of GU and breast cancer trials in his region. He previously taught at Case Western Reserve University School of Medicine, earning the 2023 Fellow Teacher of the Year Award and being inducted into the Academy of Scholars.
This podcast is brought to you by Global Management Consultancy. For more information, please visit www.globalmanagementconsultancy.com.
Disclaimer:
A. The background music used in this video is the property of its respective developer and is protected by Copyright. Although it is a free version, Business Talk, Global Management Consultancy and Deepak Bhatt do not hold the rights to this music.
B. Dr. Matthew Kurian has granted permission to share insights from the topic, “Transforming Cancer Care: How AI, Precision Medicine, and Innovative Therapies Are Shaping the Future of Oncology” on Business Talk Podcast Channel. The uploaded video contains copyrighted material; therefore, any modifications to graphics, music, or the presence of the author or host are strictly prohibited.
In God we trust